Impact BioMedical Inc (AMEX:IBO) shares, rose in value, with the stock price down by -7.87% to the previous day’s close as strong demand from buyers drove the stock to $0.40.
Actively observing the price movement in the last trading, the stock closed the session at $0.44, falling within a range of $0.3973 and $0.4317. Referring to stock’s 52-week performance, its high was $6.17, and the low was $0.37. On the whole, IBO has fluctuated by -24.04% over the past month.
With the market capitalization of Impact BioMedical Inc currently standing at about $4.63 million, investors are eagerly awaiting this quarter’s results, scheduled for in May.
The stock’s technical analysis shows that the price of IBO currently trading nearly -69.52% and -72.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.55, while the 7-day volatility ratio is showing 15.76% which for the 30-day chart, stands at 56.21%. Furthermore, Impact BioMedical Inc (IBO)’s average true range (ATR) is 0.41.
Data on historical trading for Impact BioMedical Inc (AMEX:IBO) indicates that the trading volumes over the past 10 days have averaged 13.41 and over the past 3 months, they’ve averaged 6.08 million. According to company’s latest data on outstanding shares, there are 11.50 million shares outstanding.
Nearly 15.55% of Impact BioMedical Inc’s shares belong to company insiders and institutional investors own 0.66% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.12 million shares as on 2025-03-31, resulting in a short ratio of 0.01. According to the data, the short interest in Impact BioMedical Inc (IBO) stood at 179.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 9293.0. The stock has fallen by -72.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IBO stock heading into the next quarter.
